The decision to screen for prostate cancer is a complicated one. A Cleveland Clinic medical oncologist discusses overdiagnosis and recommends a new path forward.
The physiologic roles of androgens and best-practice recommendations for androgen therapy in women.
A team of Cleveland Clinic experts considers the clinical implications of at-home COVID-19 tests in a recent article.
What to look for and how to manage symptoms of COVID-19 in the pediatric population.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
The relationship between nephrogenic systemic fibrosis and the use of gadolinium as contrast during MRI remained obscure for a long time. Cleveland Clinic nephrologists discuss the current literature, risks and updated guidelines.
Studying the ophthalmic effects of COVID-19 infection could potentially lead to earlier diagnosis and aid in disease management.
New data question the efficacy of IL-6 inhibitors for the treatment of COVID-19. This article explores what we know about the safety and efficacy of targeting IL-6.
Cleveland Clinic pulmonologists discuss the limitations of current modalities designed to treat emphysema and review the rationale, evidence and applications of valve therapy.
Clinicians have been treating community-acquired pneumonia (CAP) for centuries. Clinical and scientific discoveries have shifted the treatment paradigm over the years, but understanding current guidelines for the management of CAP remains essential.
Patients with COVID-19 who have underlying chronic lung disease are at increased risk for developing severe illness. Pulmonologist Brian Southern, MD, recently authored a review article in Cleveland Clinic Journal of Medicine’s COVID-19 Curbside Consults series. In this article, he takes a closer look at what is known about ILD and sarcoidosis in the context of the pandemic and offers insights for managing care.